Medigen Vaccine Biologics Corporation (TPEX:6547)
Taiwan · Delayed Price · Currency is TWD 35.95
+0.30 (0.84%)
Mar 4, 2026, 9:50 AM CST
Medigen Vaccine Biologics Market Cap
Medigen Vaccine Biologics has a market cap or net worth of 11.72 billion as of March 3, 2026. Its market cap has decreased by -31.44% in one year.
Market Cap
11.72B
Enterprise Value
10.34B
Revenue
594.96M
Ranking
n/a
PE Ratio
n/a
Stock Price
35.95
Market Cap Chart
Since August 6, 2015, Medigen Vaccine Biologics's market cap has increased from 2.83B to 11.72B, an increase of 313.40%. That is a compound annual growth rate of 14.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 11.90B | -4.11% |
| Dec 31, 2025 | 12.41B | 4.72% |
| Dec 31, 2024 | 11.85B | -48.55% |
| Dec 29, 2023 | 23.04B | 1.10% |
| Dec 30, 2022 | 22.78B | -64.20% |
| Dec 30, 2021 | 63.65B | 192.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EirGenix | 18.52B |
| AP Biosciences | 14.85B |
| TaiMed Biologics | 14.29B |
| Ever Supreme Bio Technology | 13.14B |
| Tanvex BioPharma | 12.87B |
| TCM Biotech International | 11.87B |
| Gongwin Biopharm Holdings | 9.94B |
| PharmaEngine | 9.21B |